About the Event
80% of late stage lung cancer patients do not get the benefit of immunotherapy because their immune systems are not “primed” to be receptive to the treatment.
Join our panel discussion with leading experts who will discuss how Photodynamic Therapy works with immunotherapy drugs to help patients get the true benefit and improve their quality of life.
- Stephen Hahn, MD: CEO-Partner of Flagship Pioneering and CEO of Harbinger Health, 24th FDA Commissioner 2019-21
- Sai Yendamuri, MD: Chair, Dept of Thoracic Surgery, and Professor of Oncology, Roswell Park Comprehensive Cancer Center
- Sandy Zinke: CEO, Lumeda